Dementia

Biomarkers in dementia with Lewy bodies: αSyn RT-QuIC

Fluid biomarkers of immune function in Alzheimer’s disease

Deep molecular profiling to identify new genetic variants and drug targets in Alzheimer’s disease

Arterial spin labelling for cerebral blood flow

Optimized anti-Aβ vaccination enters clinical trials in Alzheimer’s disease

Combining genetics and molecular biomarkers for Alzheimer’s disease prognostication

Apathy in dementia

Reactive astrocytes as therapeutic targets in neurodegenerative disease

Clinical trial assessing a multi-nutrient drink in age-related cognitive decline

Nutritional interventions to support cognitive performance in aging

Impact of race and ethnicity on greenspace-brain health associations

Diverse ancestral populations and the ADSP

Importance of ancestral background in conferring risk for genetic factors in Alzheimer’s disease

Could PDE5 inhibitors benefit dementia?

Can astrocytes influence neuropsychiatric symptoms in neurodegenerative disease?

Optimizing neighborhood and community factors for improved brain aging